Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.44 |
| ▸ | CTSC | P53634 | 1/20 | 0.43 |
| ▸ | FNTA | P49354 | 3/20 | 0.42 |
| ▸ | FNTB | P49356 | 3/20 | 0.42 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.42 |
| ▸ | ARG1 | P05089 | 1/20 | 0.41 |
| ▸ | ARG2 | P78540 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 3/20 | 0.40 |
| ▸ | ECE1 | P42892 | 1/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.39 |
| ▸ | MME | P08473 | 1/20 | 0.39 |
| ▸ | ACE | P12821 | 1/20 | 0.39 |
| ▸ | CPA1 | P15085 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL538055 | 1.00 | ALDH1A1 (0.44) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| Hydrochloric Acid SCHEMBL28446971 | 0.98 | ALDH1A1 (0.43) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| Hydrochloric Acid SCHEMBL28446972 | 0.98 | ALDH1A1 (0.43) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL29350823 | 0.94 | MMP2 (0.41) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL30052506 | 0.88 | TSHR (0.47) | LMNAFNTAFNTBPGGT1BPTGS1 | |
| SCHEMBL30052913 | 0.88 | METAP2 (0.43) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL8000185 | 0.87 | FNTA (0.48) | FNTAFNTBPGGT1BPTGS1GSTK1 | |
| SCHEMBL8000193 | 0.87 | FNTA (0.48) | FNTAFNTBPGGT1BPTGS1GSTK1 | |
| SCHEMBL30052468 | 0.85 | FNTA (0.43) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL30590002 | 0.85 | PTGS1 (0.42) | ALDH1A1LMNAMAPTPTGS2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12397012-B2 | Nucleic acid therapeutics for genetic disorders | GREENLIGHT BIOSCIENCES, INC. (US) | 2025-08-26 | — | — | US | claimed |
| CN-116171326-A | Nucleic acid therapy for genetic disorders | 绿光生物科技股份有限公司 | 2023-05-26 | — | — | CN | claimed |
| EP-4182332-A1 | NUCLEIC ACID THERAPEUTICS FOR GENETIC DISORDERS | Greenlight Biosciences, Inc. (US) | 2023-05-24 | — | — | EP | claimed |
| US-20220096525-A1 | NUCLEIC ACID THERAPEUTICS FOR GENETIC DISORDERS | GREENLIGHT BIOSCIENCES, INC. | 2022-03-31 | — | — | US | claimed |
| US-20160374380-A1 | SALTY TASTE ENHANCER | T. HASEGAWA CO., LTD. (JP) | 2016-12-29 | — | — | US | claimed |
| US-4095000-A | AMINO ACIDS AND DERIVATIVES, POLYHYDROXY COMPOUNDS, NUTRIENTS, HYDROLYSIS | Brenner, Max (CH) | 1978-06-13 | — | — | US | claimed |
| US-3959519-A | Fortification of food materials with a methionine source | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-05-25 | — | — | US | claimed |
| WO-2026089754-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES | Finitus, LLC (US) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026089752-A1 | COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES | Finitus, LLC (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260108467-A1 | COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES | FINITUS LLC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260108583-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES | FINITUS LLC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260036547-A1 | METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM | ASTRAZENECA AB (SE) | 2026-02-05 | — | — | US | disclosed |
| US-12397012-B2 | Nucleic acid therapeutics for genetic disorders | GREENLIGHT BIOSCIENCES, INC. (US) | 2025-08-26 | — | — | US | disclosed |
| US-4303692-A | TAURINE ADDITIVE | ABBOTT LABORATORIES | 1981-12-01 | — | — | US | disclosed |
| US-4235942-A | LOW MOLECULAR WEIGHT POLYAMINO ACIDS FOR NUTRITIONAL FORTIFICATION | STANDARD OIL COMPANY (INDIANA) (US) | 1980-11-25 | — | — | US | disclosed |
| EP-0015668-A1 | Digestible polyamino acids, method for preparing them and food fortified with the digestible polyamino acids | Standard Oil Company (US) | 1980-09-17 | — | — | EP | disclosed |
| US-4095000-A | AMINO ACIDS AND DERIVATIVES, POLYHYDROXY COMPOUNDS, NUTRIENTS, HYDROLYSIS | Brenner, Max (CH) | 1978-06-13 | — | — | US | disclosed |
| US-4024286-A | Fortification of foodstuffs with C-terminal amino acid substituted methionine dipeptides | MILES LABORATORIES, INC. (US) | 1977-05-17 | — | — | US | disclosed |
| US-3959519-A | Fortification of food materials with a methionine source | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-05-25 | — | — | US | disclosed |
| US-3959519-A | Fortification of food materials with a methionine source | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108583-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES | MUC1, VIP, LGALS4 | ALDH1A1 3706/4885LMNA 1681/4885MAPT 2398/4885 |
| US-20260108467-A1 | COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES | FGF23, FIBP, PTMS | ALDH1A1 2847/4885LMNA 3506/4885MAPT 1252/4885 |
| US-20260036547-A1 | METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM | ATP5ME, ATP5MF, ATP5MK | ALDH1A1 1687/4885LMNA 3325/4885MAPT 3490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.